Literature DB >> 30385692

Fas activation alters tight junction proteins in acute lung injury.

Raquel Herrero1,2, Lucia Prados3, Antonio Ferruelo1, Ferranda Puig1,4, Rachele Pandolfi5, Raquel Guillamat-Prats1,4, Laura Moreno1,5,6, Gustavo Matute-Bello7, Antonio Artigas4, Andres Esteban1,8, José Ángel Lorente1,2,8.   

Abstract

Background:The acute respiratory distress syndrome (ARDS) is characterized by protein-rich oedema in the alveolar spaces, a feature in which Fas-mediated apoptosis of the alveolar epithelium has been involved. Objective:To determine whether Fas activation increases protein permeability by mechanisms involving disruption of the paracellular tight junction (TJ) proteins in the pulmonary alveoli.
Methods: Protein permeability and the expression of TJ proteins were assessed in vivo in wild-type and Fas-deficient lpr mice 16 hours after the intratracheal instillation of recombinant human soluble Fas ligand (rh-sFasL), and at different time points in vitro in human pulmonary alveolar epithelial cells (HPAEpiC) exposed to rh-sFasL
Results: Activation of the Fas pathway increased protein permeability in mouse lungs and altered the expression of the TJ proteins occludin and zonula occludens-1 in the alveolar-capillary membrane in vivo and in human alveolar epithelial cell monolayers in vitro. Blockade of caspase-3, but not inhibition of tyrosine kinase dependent pathways, prevented the alterations in TJ protein expression and permeability induced by the Fas/FasL system in human alveolar cell monolayers in vitro. We also observed that both the Fas-induced increase of protein permeability and disruption of TJ proteins occurred before cell death could be detected in the cell monolayers in vitro.
Conclusion: Targeting caspase pathways could prevent the disruption of TJs and reduce the formation of lung oedema in the early stages of ARDS. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  ards; innate immunity; pulmonary oedema

Mesh:

Substances:

Year:  2018        PMID: 30385692      PMCID: PMC6339809          DOI: 10.1136/thoraxjnl-2018-211535

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  38 in total

1.  Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells.

Authors:  Y h Chen; Q Lu; E E Schneeberger; D A Goodenough
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

2.  Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia.

Authors:  S V Walsh; A M Hopkins; J Chen; S Narumiya; C A Parkos; A Nusrat
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

3.  The specific fates of tight junction proteins in apoptotic epithelial cells.

Authors:  Christian Bojarski; Jörg Weiske; Torsten Schöneberg; Werner Schröder; Joachim Mankertz; Jörg-Dieter Schulzke; Peter Florian; Michael Fromm; Rudolf Tauber; Otmar Huber
Journal:  J Cell Sci       Date:  2004-03-30       Impact factor: 5.285

Review 4.  Structure, function, and regulation of cellular tight junctions.

Authors:  E E Schneeberger; R D Lynch
Journal:  Am J Physiol       Date:  1992-06

5.  Intact epithelial barrier function is critical for the resolution of alveolar edema in humans.

Authors:  M A Matthay; J P Wiener-Kronish
Journal:  Am Rev Respir Dis       Date:  1990-12

6.  Nonreceptor tyrosine kinase c-Yes interacts with occludin during tight junction formation in canine kidney epithelial cells.

Authors:  Yan-Hua Chen; Qun Lu; Daniel A Goodenough; Beverly Jeansonne
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

7.  Claudin-4 augments alveolar epithelial barrier function and is induced in acute lung injury.

Authors:  Charlie Wray; Ying Mao; Jue Pan; Anita Chandrasena; Frank Piasta; James A Frank
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-15       Impact factor: 5.464

8.  Decreased distribution of lung epithelial junction proteins after intratracheal antigen or lipopolysaccharide challenge: correlation with neutrophil influx and levels of BALF sE-cadherin.

Authors:  Steven M Evans; David I Blyth; Tony Wong; Shahin Sanjar; Michael R West
Journal:  Am J Respir Cell Mol Biol       Date:  2002-10       Impact factor: 6.914

Review 9.  Modulation of tight junction structure and function by kinases and phosphatases targeting occludin.

Authors:  Max Johannes Dörfel; Otmar Huber
Journal:  J Biomed Biotechnol       Date:  2012-01-23

10.  Upregulation of the tight junction protein occludin: effects on ventilation-induced lung injury and mechanisms of action.

Authors:  Mengjie Liu; Changping Gu; Yuelan Wang
Journal:  BMC Pulm Med       Date:  2014-05-29       Impact factor: 3.317

View more
  9 in total

Review 1.  Tight Junctions, the Epithelial Barrier, and Toll-like Receptor-4 During Lung Injury.

Authors:  Nachiket M Godbole; Asif Alam Chowdhury; Neha Chataut; Shanjana Awasthi
Journal:  Inflammation       Date:  2022-07-02       Impact factor: 4.657

Review 2.  Tight Junction Proteins and the Biology of Hepatobiliary Disease.

Authors:  Natascha Roehlen; Armando Andres Roca Suarez; Houssein El Saghire; Antonio Saviano; Catherine Schuster; Joachim Lupberger; Thomas F Baumert
Journal:  Int J Mol Sci       Date:  2020-01-28       Impact factor: 5.923

Review 3.  Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review.

Authors:  Tara Talaie; Laura DiChiacchio; Nikhil K Prasad; Chetan Pasrija; Walker Julliard; David J Kaczorowski; Yunge Zhao; Christine L Lau
Journal:  Transplant Direct       Date:  2021-01-07

4.  SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.

Authors:  Pablo Juanes-Velasco; Alicia Landeira-Viñuela; Marina L García-Vaquero; Quentin Lecrevisse; Raquel Herrero; Antonio Ferruelo; Rafael Góngora; Fernando Corrales; Javier De Las Rivas; Jose A Lorente; Ángela-Patricia Hernández; Manuel Fuentes
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

5.  Investigating the Intercellular Communication Network of Immune Cell in Acute Respiratory Distress Syndrome with Sepsis.

Authors:  Pei Tao; Jinzhou He; Tao Ai; Yinghong Fan; Wei Zeng
Journal:  Comput Math Methods Med       Date:  2022-02-16       Impact factor: 2.238

6.  Sevoflurane Dampens Acute Pulmonary Inflammation via the Adenosine Receptor A2B and Heme Oxygenase-1.

Authors:  Kristian-Christos Ngamsri; Anika Fuhr; Katharina Schindler; Mariana Simelitidis; Michelle Hagen; Yi Zhang; Jutta Gamper-Tsigaras; Franziska M Konrad
Journal:  Cells       Date:  2022-03-24       Impact factor: 6.600

7.  The bioactivity of soluble Fas ligand is modulated by key amino acids of its stalk region.

Authors:  Osamu Kajikawa; Raquel Herrero; Yu-Hua Chow; Chi F Hung; Gustavo Matute-Bello
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

8.  Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation.

Authors:  Kristian-Christos Ngamsri; Christoph Jans; Rizki A Putri; Katharina Schindler; Jutta Gamper-Tsigaras; Claudia Eggstein; David Köhler; Franziska M Konrad
Journal:  Front Immunol       Date:  2020-03-10       Impact factor: 7.561

9.  Targeting MALAT1 and miRNA-181a-5p for the intervention of acute lung injury/acute respiratory distress syndrome.

Authors:  Yaling Liu; Xiaodong Wang; Peiying Li; Yanhua Zhao; Liqun Yang; Weifeng Yu; Hong Xie
Journal:  Respir Res       Date:  2021-01-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.